EXTENDED REPORT

¹ Department of Rheumatology, Basle University, Felix Platter Spital, Basel, Switzerland
² University of Pécs, Department of Immunology and Rheumatology, Pécs, Hungary
³ Centre for Rheumatology, Royal Free and University College London Medical School, London, UK
⁴ Department of Internal Medicine, Hospital Saint Louis, Paris, France
⁵ Department of Rheumatology, Medical University of Bialystok, Biolystok, Poland
⁶ Department of Rheumatology Kerckhoff Klinik, Bad Nauheim, Germany
⁷ Department of Internal Medicine, Section of Rheumatology, University of Florence, Italy

Correspondence to:
U A Walker
Department of Rheumatology, Basle University, Felix Platter Spital, Burgfelderstrasse 101, Basel 4012, Switzerland;ulrich.walker{at}fps-basel.ch

Background: Systemic sclerosis (SSc) is a multisystem autoimmune disease, which is classified into a diffuse cutaneous (dcSSc) and a limited cutaneous (lcSSc) subset according to the skin involvement. In order to better understand the vascular, immunological and fibrotic processes of SSc and to guide its treatment, the EULAR Scleroderma Trials And Research (EUSTAR) group was formed in June 2004.

Aims and methods: EUSTAR collects prospectively the Minimal Essential Data Set (MEDS) on all sequential patients fulfilling the American College of Rheumatology diagnostic criteria in participating centres. We aimed to characterise demographic, clinical and laboratory characteristics of disease presentation in SSc and analysed EUSTAR baseline visits.

Results: In April 2006, a total of 3656 patients (1349 with dcSSc and 2101 with lcSSc) were enrolled in 102 centres and 30 countries. 1330 individuals had autoantibodies against Scl70 and 1106 against anticentromere antibodies. 87% of patients were women. On multivariate analysis, scleroderma subsets (dcSSc vs lcSSc), antibody status and age at onset of Raynaud’s phenomenon, but not gender, were found to be independently associated with the prevalence of organ manifestations. Autoantibody status in this analysis was more closely associated with clinical manifestations than were SSc subsets.

Conclusion: dcSSc and lcSSc subsets are associated with particular organ manifestations, but in this analysis the clinical distinction seemed to be superseded by an antibody-based classification in predicting some scleroderma complications. The EUSTAR MEDS database facilitates the analysis of clinical patterns in SSc, and contributes to the standardised assessment and monitoring of SSc internationally.

Abbreviations: ACA, anticentromere autoantibody; ACR, American College of Rheumatology; CK, creatine kinase; dcSSc, diffuse cutaneous systemic sclerosis; EUSTAR, EULAR Scleroderma Trials And Research; lcSSc, limited cutaneous systemic scerosis; PAH, pulmonary artery hypertension (assessed by echocardiography); SSc, sytemic sclerosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Matucci-Cerinic, M, Allanore, Y, Czirjak, L, Tyndall, A, Muller-Ladner, U, Denton, C, Valentini, G, Distler, O, Fligelstone, K, Tyrrel-Kennedy, A, Farge, D, Kowal-Bielecka, O, van den Hoogen, F, Cutolo, M, Sampaio-Barros, P D, Nash, P, Takehara, K, Furst, D E (2009). The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 68: 1377-1380 [Abstract] [Full Text]  
• Vonk, M C, Broers, B, Heijdra, Y F, Ton, E, Snijder, R, van Dijk, A P J, van Laar, J M, Bootsma, H, van Hal, P T. W, van den Hoogen, F H J, van Daele, P L A (2009). Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study. Ann Rheum Dis 68: 961-965 [Abstract] [Full Text]  
• Walker, U A, Tyndall, A, Czirjak, L, Denton, C P, Farge-Bancel, D, Kowal-Bielecka, O, Muller-Ladner, U, Matucci-Cerinic, M, and the EUSTAR co-authors, (2009). Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database. Ann Rheum Dis 68: 856-862 [Abstract] [Full Text]  
• Avouac, J, Kowal-Bielecka, O, Landewe, R, Chwiesko, S, Miniati, I, Czirjak, L, Clements, P, Denton, C, Farge, D, Fligelstone, K, Foldvari, I, Furst, D E, Muller-Ladner, U, Seibold, J, Silver, R M, Takehara, K, Toth, B G., Tyndall, A, Valentini, G, van den Hoogen, F, Wigley, F, Zulian, F, Matucci-Cerinic, M, and EUSTAR coauthors, (2009). European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research. Ann Rheum Dis 68: 629-634 [Abstract] [Full Text]  
• LOW, A. H.L., JOHNSON, S. R., LEE, P. (2009). Ethnic Influence on Disease Manifestations and Autoantibodies in Chinese-Descent Patients with Systemic Sclerosis. The Journal of Rheumatology 36: 787-793 [Abstract] [Full Text]  
• Hugle, T, Gratzl, S, Daikeler, T, Frey, D, Tyndall, A, Walker, U A (2009). Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced?. Ann Rheum Dis 68: 47-50 [Abstract] [Full Text]  
• Hanitsch, L. G., Burmester, G.-R., Witt, C., Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Muller-Ladner, U., Schulze-Lohoff, E., Becker, M., Sunderkoetter, C., the DNSS centers, , Riemekasten, G. (2009). Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) 48: 70-73 [Abstract] [Full Text]  
• Smith, V, Vanthuyne, M, Vander Cruyssen, B, Van Praet, J, Vermeiren, F, Smets, H, Houssiau, F, De Keyser, F (2008). Over-representation of construction-related occupations in male patients with systemic sclerosis. Ann Rheum Dis 67: 1448-1450 [Abstract] [Full Text]  
• Rozman, B, Cucnik, S, Sodin-Semrl, S, Czirjak, L, Varju, C, Distler, O, Huscher, D, Aringer, M, Steiner, G, Matucci-Cerinic, M, Guiducci, S, Stamenkovic, B, Stankovic, A, Kveder, T (2008). Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case-control study. Ann Rheum Dis 67: 1282-1286 [Abstract] [Full Text]  
• Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Moinzadeh, P., Muller-Ladner, U., Pfeiffer, C., Riemekasten, G., Schulze-Lohoff, E., Sunderkoetter, C., Weber, M., Worm, M., Klaus, P., Rubbert, A., Steinbrink, K., Grundt, B., Hein, R., Scharffetter-Kochanek, K., Hinrichs, R., Walker, K., Szeimies, R.-M., Karrer, S., Muller, A., Seitz, C., Schmidt, E., Lehmann, P., Foeldvari, I., Reichenberger, F., Gross, W.L., Kuhn, A., Haust, M., Reich, K., Bohm, M., Saar, P., Fierlbeck, G., Kotter, I., Lorenz, H.-M., Blank, N., Grafenstein, K., Juche, A., Aberer, E., Bali, G., Fiehn, C., Stadler, R., Bartels, V. (2008). The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 47: 1185-1192 [Abstract] [Full Text]  
• Hettema, M. E., Bootsma, H., Kallenberg, C. G. M. (2008). Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 47: 578-583 [Abstract] [Full Text]  
• Larghero, J, Farge, D, Braccini, A, Lecourt, S, Scherberich, A, Fois, E, Verrecchia, F, Daikeler, T, Gluckman, E, Tyndall, A, Bocelli-Tyndall, C (2008). Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann Rheum Dis 67: 443-449 [Abstract] [Full Text]